- MBio Diagnostics, Inc. was acquired by Heska Corporation (NasdaqCM:HSKA)
- Biosynex SA (ENXTPA:ALBIO) announced its acquisition of Theradiag SA
- RayzeBio, Inc. closed a $160mm Series A Financing, led by Sofinnova Investment, Inc., Laurion Capital Management LP, Sectoral Asset Management Inc., Boyu Capital Consultancy Co. Ltd., British Patient Capital Limited, and StartX
BlueBook
Diagnostics and Tools September 2022
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.